Watch Cepheid's ECCMID 2024 Integrated Symposium Now
In Cepheid’s Integrated Symposium at ECCMID 2024, delegates heard from leaders in their field from across Europe present contemporary data, meta-analysis and real-world live experience on current and emerging healthcare threats – notably the ongoing challenges of circulating respiratory viruses and ever-increasing risk of antimicrobial resistance including carbapenemases and MRSA – and novel role of diagnostics in innovating patient management, infection control and antimicrobial stewardship.
Catch up with the recorded Cepheid Integrated Symposium below.
“Innovating Rapid Molecular Diagnostics for Infectious Diseases: Real World Impact on Patient Care”
Chair: Dr. Beryl Oppenheim, Senior Director Medical Affairs, Cepheid, UK
ESCMID-appointed Chair: Dr. Mariska Leeflang, Associate Professor, Amsterdam UMC, Netherland
"Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: results of a systematic review and meta-analysis"
Tristan Clark, Professor and Honorary Consultant in Infectious Diseases
University Hospital Southampton NHS Foundation Trust, UK
"Management of respiratory diseases in the emergency department"
Clemens Kill, Director, Center of Emergency Medicine
Essen University, Germany
"Catching the ESKAPEs: can rapid surveillance impact our control efforts?"
Valeria Cento, Associate Professor of Microbiology
Humanitas Research Hospital, Italy
"Novel approaches to CDI patient management with rapid PCR"
Elena Reigadas, Microbiologist
Hospital General Universitario Gregorio Marañón, Spain
We hope you enjoy the expert insight shared during our Integrated Symposium at ECCMID 2024!
References
CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
